Phathom Pharmaceuticals PHAT
NASDAQ PHAT
$7.03 -0.28 (-3.90%)
As of: Oct 21, 2026 · 3:59 PM EDT

Phathom Pharmaceuticals (PHAT) Long-Term Debt Issuances (2020 - 2026)

Updated

Phathom Pharmaceuticals (PHAT) posted Long-Term Debt Issuances of $173.25 million for Q1 2026.

Analysis

Phathom Pharmaceuticals (PHAT) Long-Term Debt Issuances (2020 - 2026) Analysis & Trends

For FY2024, Phathom Pharmaceuticals' Long-Term Debt Issuances came in at $59.4 million, up 51.1% from FY2023.

  • Annual Long-Term Debt Issuances shows a five-year compound annual growth rate of 19.0% (FY2019 to FY2024).
  • In prior years, Phathom Pharmaceuticals' Long-Term Debt Issuances was $39.32 million in FY2023, $96.89 million in FY2021 (+287.6%) and $25 million in FY2020 (+0.6%).
  • The Q1 2026 figure stands as the lowest quarterly Long-Term Debt Issuances since Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 8.94 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 1.98 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Phathom Pharmaceuticals 587.90 Mn -52.05 Mn 59.18 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 173.25 Mn
Dec 31, 2024 24.75 Mn
Jun 30, 2024 24.75 Mn
Mar 31, 2024 9.90 Mn
Dec 31, 2023 39.32 Mn
Mar 31, 2020 25.00 Mn
API Access

Phathom Pharmaceuticals Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=PHAT&period=max&api_key=YOUR_API_KEY